https://charts.traderzeitung.de/phases/US75629V1044
string(1521) "{"isin":"US75629V1044","name":"Recursion Pharmaceuticals Inc","stock_id_xnas":20512096,"stock_id_xnys":null,"generated_at":"2026-08-23 22:39:00","days":[{"date":"2026-08-19","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":3.29,"close_at":"2026-08-19 15:29:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.49,"close_at":"2026-08-19 21:59:00","complete":true,"perf_pct":6.079},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":3.45,"close_at":"2026-08-20 01:34:00","complete":true,"perf_pct":-1.1461}]},{"date":"2026-08-20","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":3.4,"close_at":"2026-08-20 15:29:00","complete":true,"perf_pct":-1.4493},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.335,"close_at":"2026-08-20 21:59:00","complete":true,"perf_pct":-1.9118},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":3.33,"close_at":"2026-08-21 01:07:00","complete":true,"perf_pct":-0.1499}]},{"date":"2026-08-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":3.38,"close_at":"2026-08-21 15:29:00","complete":true,"perf_pct":1.5015},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.495,"close_at":"2026-08-21 21:59:00","complete":true,"perf_pct":3.4024},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":3.51,"close_at":"2026-08-21 23:46:00","complete":true,"perf_pct":0.4292}]}]}"
Recursion Pharmaceuticals Aktie News & Nachrichten
Trading-Room

Recursion Pharmaceuticals Aktie News & Nachrichten

[WKN: A3CM1C | Symbol: RXRX]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Recursion Pharmaceuticals

Recursion Pharma - Wirkstoffentwickler profitiert von steigenden F&E-Ausgaben in der Pharma- und Biotechindustrie!

Geschäftstreiber: Recursion Pharma (RXRX) hat sich im Bereich Wirkstoff-Entwicklung mit Schwerpunkt...

Recursion Pharma - Wirkstoffentwickler profitiert von steigenden F&E-Ausgaben in der Pharma- und Biotechindustrie!

Geschäftstreiber: Recursion Pharma (RXRX) gehört zu den technologisch führenden Anbietern im Bereich...

  • ‹
  • 1
  • ›
Recursion Pharmaceuticals Nachrichtenticker öffnen
MT Newswires 17.08.2026 17:02 Uhr

Research-Alert: Contineum, Disc Medicine, Recursion bringen Pipelines vor wichtigen Katalysatoren voran, so Morgan Stanley

11:01 AM EDT, 17.08.2026 (MT Newswires) -- Contineum Therapeutics (CTNM), Disc Medicine (IRON) und Recursion Pharmaceuticals (RXRX) erzielen bedeutend

MT Newswires 17.08.2026 11:55 Uhr

Morgan Stanley passt Kursziel für Recursion Pharmaceuticals von 5,50 $ auf 5,30 $ an, belässt Einstufung auf Equalweight

05:54 AM EDT, 17.08.2026 (MT Newswires) -- Recursion Pharmaceuticals (RXRX) hat laut von FactSet befragten Analysten ein durchschnittliches Rating von

MT Newswires 05.08.2026 15:54 Uhr

Recursion Pharmaceuticals Aktien fallen nach verfehlten Q2-Zahlen

09:53 AM EDT, 08/05/2026 (MT Newswires) -- Die Aktien von Recursion Pharmaceuticals (RXRX) fielen im frühen Mittwochshandel um 4,2%, nachdem das Unter

MT Newswires 05.08.2026 12:53 Uhr

Earnings Flash (RXRX) Recursion Pharmaceuticals meldet Q2 Verlust von 0,25 USD je Aktie, verglichen mit FactSet-Schätzung von 0,28 USD Verlust

06:45 AM EDT, 08/05/2026 (MT Newswires) -- http://www.mtnewswires.com Copyright © 2026 MT Newswires. All rights reserved. MT Newswires does not provid

MT Newswires 05.08.2026 12:46 Uhr

-- Earnings Flash (RXRX) Recursion Pharmaceuticals Inc meldet Q2-Umsatz von $7,7M

06:36 AM EDT, 08/05/2026 (MT Newswires) -- http://www.mtnewswires.com Copyright © 2026 MT Newswires. All rights reserved. MT Newswires does not provid